Unknown

Dataset Information

0

Evasion of immunosurveillance by genomic alterations of PPAR?/RXR? in bladder cancer.


ABSTRACT: Muscle-invasive bladder cancer (MIBC) is an aggressive disease with limited therapeutic options. Although immunotherapies are approved for MIBC, the majority of patients fail to respond, suggesting existence of complementary immune evasion mechanisms. Here, we report that the PPAR?/RXR? pathway constitutes a tumor-intrinsic mechanism underlying immune evasion in MIBC. Recurrent mutations in RXR? at serine 427 (S427F/Y), through conformational activation of the PPAR?/RXR? heterodimer, and focal amplification/overexpression of PPAR? converge to modulate PPAR?/RXR?-dependent transcription programs. Immune cell-infiltration is controlled by activated PPAR?/RXR? that inhibits expression/secretion of inflammatory cytokines. Clinical data sets and an in vivo tumor model indicate that PPAR?High/RXR?S427F/Y impairs CD8+ T-cell infiltration and confers partial resistance to immunotherapies. Knockdown of PPAR? or RXR? and pharmacological inhibition of PPAR? significantly increase cytokine expression suggesting therapeutic approaches to reviving immunosurveillance and sensitivity to immunotherapies. Our study reveals a class of tumor cell-intrinsic "immuno-oncogenes" that modulate the immune microenvironment of cancer.Muscle-invasive bladder cancer (MIBC) is a potentially lethal disease. Here the authors characterize diverse genetic alterations in MIBC that convergently lead to constitutive activation of PPARgamma/RXRalpha and result in immunosurveillance escape by inhibiting CD8+ T-cell recruitment.

SUBMITTER: Korpal M 

PROVIDER: S-EPMC5524640 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.

Korpal Manav M   Puyang Xiaoling X   Jeremy Wu Zhenhua Z   Seiler Roland R   Furman Craig C   Oo Htoo Zarni HZ   Seiler Michael M   Irwin Sean S   Subramanian Vanitha V   Julie Joshi Jaya J   Wang Chris K CK   Rimkunas Victoria V   Tortora Davide D   Yang Hua H   Kumar Namita N   Kuznetsov Galina G   Matijevic Mark M   Chow Jesse J   Kumar Pavan P   Zou Jian J   Feala Jacob J   Corson Laura L   Henry Ryan R   Selvaraj Anand A   Davis Allison A   Bloudoff Kristjan K   Douglas James J   Kiss Bernhard B   Roberts Morgan M   Fazli Ladan L   Black Peter C PC   Fekkes Peter P   Smith Peter G PG   Warmuth Markus M   Yu Lihua L   Hao Ming-Hong MH   Larsen Nicholas N   Daugaard Mads M   Zhu Ping P  

Nature communications 20170724 1


Muscle-invasive bladder cancer (MIBC) is an aggressive disease with limited therapeutic options. Although immunotherapies are approved for MIBC, the majority of patients fail to respond, suggesting existence of complementary immune evasion mechanisms. Here, we report that the PPARγ/RXRα pathway constitutes a tumor-intrinsic mechanism underlying immune evasion in MIBC. Recurrent mutations in RXRα at serine 427 (S427F/Y), through conformational activation of the PPARγ/RXRα heterodimer, and focal a  ...[more]

Similar Datasets

| S-EPMC7884830 | biostudies-literature
| S-EPMC3539437 | biostudies-literature
| S-EPMC7082404 | biostudies-literature
| S-EPMC4425662 | biostudies-literature
| S-EPMC3753703 | biostudies-literature
| S-EPMC3226690 | biostudies-literature
| S-EPMC4731802 | biostudies-literature
| S-EPMC9938131 | biostudies-literature
2020-11-01 | GSE122514 | GEO
| S-EPMC2672886 | biostudies-literature